By Mike Curley ( January 16, 2020, 6:56 PM EST) -- A Ninth Circuit panel on Thursday rejected an appeal by users of the antidepressant Cymbalta who claimed maker Eli Lilly & Co. hid the risks of withdrawal from the drug, saying they knew they might be ending the case when they initially dropped their claims....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.